Advanced search
Publication Cover
Emerging Microbes & Infections Latest Articles
Submit an article Journal homepage
788
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Epidemic Features and Megagenomic Analysis of Childhood Mycoplasma Pneumoniae post COVID-19 Pandemic: A 6-year Study in Southern China

Yi Xua Department of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China;b Prenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China;c Department of Infectious Diseases, Guangzhou Children's Hospital, Guangzhou, ChinaView further author information
,
Chen Yangb Prenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China;d Faculty of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, ChinaView further author information
,
Panpan Sund Faculty of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, ChinaView further author information
,
Fansen Zenga Department of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China;c Department of Infectious Diseases, Guangzhou Children's Hospital, Guangzhou, ChinaView further author information
,
Qian Wanga Department of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China;c Department of Infectious Diseases, Guangzhou Children's Hospital, Guangzhou, ChinaView further author information
,
Jianlong Wue Department of Pharmacy, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, ChinaView further author information
,
Chunxiao Fanga Department of Pediatrics, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China;f Department of Surgery, The University of Hong Kong Shenzhen Hospital, Shenzhen, ChinaView further author information
,
Che Zhangh Department of Pharmacy, South China Hospital, Medical School, Shenzhen University, Shenzhen, ChinaView further author information
,
Jinping Wange Department of Pharmacy, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, ChinaView further author information
,
Yiling Guc Department of Infectious Diseases, Guangzhou Children's Hospital, Guangzhou, China;g Department of Pediatrics, Guangzhou Maternal and Child Health Hospital, Guangzhou, ChinaView further author information
,
Xiaohuan Wuc Department of Infectious Diseases, Guangzhou Children's Hospital, Guangzhou, China;g Department of Pediatrics, Guangzhou Maternal and Child Health Hospital, Guangzhou, ChinaView further author information
,
Xiaoxian Zhangb Prenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, ChinaView further author information
,
Bin Yangi Vision Medicals Co., Ltd., Guangzhou, ChinaView further author information
,
Juhua Yangi Vision Medicals Co., Ltd., Guangzhou, ChinaView further author information
,
Hongwei Zhangj Department of Navy Epidemiology, Faculty of Naval Medicine, Naval Medical University (Second Military Medical University), Shanghai, ChinaView further author information
,
Jiacee Liank School of Health Sciences, Ngee Ann Polytechnic, SingaporeView further author information
,
Jinqiu Zhangb Prenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, ChinaView further author information
,
Li Huange Department of Pharmacy, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, China;d Faculty of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China;b Prenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, ChinaCorrespondence[email protected] [email protected]
View further author information
&
Qizhou Liand Faculty of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China;b Prenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, China;f Department of Surgery, The University of Hong Kong Shenzhen Hospital, Shenzhen, ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Article: 2353298 | Accepted author version posted online: 09 May 2024
Accepted author version

References

  • [1] Atkinson TP, Balish MF, Waites KB. Epidemiology, clinical manifestations, pathogenesis and laboratory detection ofMycoplasma pneumoniaeinfections: Figure 1. FEMS Microbiology Reviews. 2008;32(6):956-73.
  • [2] Vervloet LA, Marguet C, Camargos PAM. Infection by Mycoplasma pneumoniae and its importance as an etiological agent in childhood community-acquired pneumonias. Braz J Infect Dis. 2007;11(5):507-14.
  • [3] Meyer Sauteur PM, Beeton ML, Pereyre S, et al. Mycoplasma pneumoniae: delayed re- emergence after COVID-19 pandemic restrictions. The Lancet Microbe. 2023.
  • [4] Maeve Cullinan. Child pneumonia cases emerge in Europe as China battles wave of respiratory illness. The Telegraph. 2023. https://www.telegraph.co.uk/global- health/science-and-disease/child-pneumonia-europe-france-ireland-denmark-netherlands/.
  • [5] Statens Serum Institut (Danish disease agency). Increased occurrence of Mycoplasma pneumoniae. 2023. https://en.ssi.dk/news/epi-news/2023/no-35---2023.
  • [6] WHO. Upsurge of respiratory illnesses among children-Northern China. 2023. https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON494.
  • [7] WHO. WHO statement on reported clusters of respiratory illness in children in northern China. 2023. https://www.who.int/news/item/22-11-2023-who-statement-on-reported-clusters-of-respiratory-illness-in-children-in-northern-china.
  • [8] Chen B, Wang M, Huang X, et al. Changes in incidence of notifiable infectious diseases in China under the prevention and control measures of COVID-19. Front Public Health. 2021;9:728768.
  • [9] Wang L, Guo X, Zhao N, et al. Effects of the enhanced public health intervention during the COVID-19 epidemic on respiratory and gastrointestinal infectious diseases in China. J Med Virol. 2022;94(5):2201-11.
  • [10] Soo RJJ, Chiew CJ, Ma S, et al. Decreased influenza incidence under COVID-19 control measures, Singapore. Emerg Infect Dis. 2020;26(8):1933-5.
  • [11] Feng L, Zhang T, Wang Q, et al. Impact of COVID-19 outbreaks and interventions on influenza in China and the United States. Nat Commun. 2021;12(1):3249.
  • [12] Zhang Y, Huang Y, Ai T, et al. Effect of COVID-19 on childhood Mycoplasma pneumoniae infection in Chengdu, China. BMC Pediatrics. 2021;21(1).
  • [13] Xu M, Liu P, Su L, et al. Comparison of Respiratory Pathogens in Children With Lower Respiratory Tract Infections Before and During the COVID-19 Pandemic in Shanghai, China. Frontiers in Pediatrics. 2022;10.
  • [14] Chen J, Zhang J, Lu Z, et al. Mycoplasma pneumoniae among chinese outpatient children with mild respiratory tract infections during the coronavirus disease 2019 pandemic. Microbiol Spectr. 2022;10(1):e0155021.
  • [15] The National Health Commission of the People's Republic of China. Prevention and control strategy of 2019-novel coronavirus (version 9). 2022. http://chrome-extension://ibllepbpahcoppkjjllbabhnigcbffpi/http://www.gov.cn/xinwen/2022-06/28/5698168/files/9585944023424f45a4b4d522b5f5c034.pdf. Accessed 23 Dec 2022.
  • [16] Group CMAPBR, Board CJoPPE. Expert consensus on the diagnosis and treatment of Mycoplasma pneumoniae pneumonia in children (2015 version). Chinese Journal of Practical Pediatrics. 2015;30(17):1304-8.
  • [17] Group NHCCECoRDUPDUP. Chinese expert consensus on laboratory diagnosis standard and clinical practice for Mycoplasma pneumoniae infection in children (2019 version). Chinese Journal of Pediatrics. 2020;58(5):366-73.
  • [18] Huang L, Yang C, Pan H, et al. Effects of public health interventions and zero COVID policy on paediatric diseases: A Southern China study. Journal of Global Health. 2024;14.
  • [19] Kuitunen I, Artama M, Mäkelä L, et al. Effect of social distancing due to the COVID-19 pandemic on the incidence of viral respiratory tract infections in children in Finland during early 2020. Pediatric Infectious Disease Journal. 2020;39(12):e423-e7.
  • [20] Saravanos GL, Hu N, Homaira N, et al. RSV epidemiology in Australia before and during COVID-19. Pediatrics. 2022;149(2).
  • [21] Teirlinck AC, Johannesen CK, Broberg EK, et al. New perspectives on respiratory syncytial virus surveillance at the national level: lessons from the COVID-19 pandemic. European Respiratory Journal. 2023;61(4):2201569.
  • [22] Cheng Y, Cheng Y, Dai S, et al. The prevalence of Mycoplasma pneumoniae among children in Beijing before and during the COVID-19 pandemic. Frontiers in Cellular and Infection Microbiology. 2022;12.
  • [23] Cai F, Shou X, Ye Q. Epidemiological study on Mycoplasma pneumoniae and Chlamydia pneumoniae infection of hospitalized children in a single center during the COVID-19 pandemic. Front Cell Infect Microbiol. 2022;12:843463.
  • [24] Wang H, Zheng Y, de Jonge MI, et al. Lockdown measures during the COVID-19 pandemic strongly impacted the circulation of respiratory pathogens in Southern China. Scientific Reports. 2022;12(1).
  • [25] Feng Y, Zhang H, Zhang B, et al. Impact of normalized COVID-19 prevention and control measures on lower respiratory tract infection pathogenesis in hospitalized children. Frontiers in Public Health. 2024;12.
  • [26] Li L, Wang H, Liu A, et al. Comparison of 11 respiratory pathogens among hospitalized children before and during the COVID-19 epidemic in Shenzhen, China. Virology Journal. 2021;18(1).
  • [27] Zhang LN, Cao L, Meng LH. Pathogenic changes of community-acquired pneumonia in a children's hospital in Beijing, China before and after COVID-19 onset: a retrospective study. World journal of pediatrics : WJP. 2022;18(11):746-52.
  • [28] Mai W, Ren Y, Tian X, et al. Comparison of common human respiratory pathogens among hospitalized children aged ≤ 6 years in Hainan Island, China, during spring and early summer in 2019-2021. J Med Virol. 2023;95(4):e28692.
  • [29] Chen J, Zhang J, Lu Z, et al. Mycoplasma pneumoniae among Chinese outpatient children with mild respiratory tract infections during the coronavirus disease 2019 pandemic. Microbiol Spectr. 2022;10(1):e0155021.
  • [30] Zhou D, del Valle-Mendoza J, Orellana-Peralta F, et al. High Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Acute Respiratory Infections from Lima, Peru. Plos One. 2017;12(1):e0170787.
  • [31] Ambooken B, Balakrishnan PP, Asokan N, et al. Ulcerated lobular panniculitis: An unusual initial presentation of anti-Mi-2-alpha positive dermatomyositis. Indian Journal of Dermatology, Venereology and Leprology. 2022;88:381-4.
  • [32] Silva SJRd, Pena L. Collapse of the public health system and the emergence of new variants during the second wave of the COVID-19 pandemic in Brazil. One Health. 2021;13:100287.
  • [33] Wang A, Wu Z, Huang Y, et al. A 3D-printed microfluidic device for qPCR detection of macrolide-resistant mutations of mycoplasma pneumoniae. Biosensors. 2021;11(11):427.
  • [34] Zhan X-W, Deng L-P, Wang Z-Y, et al. Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia. Italian Journal of Pediatrics. 2022;48(1).
  • [35] Li H, Li S, Yang H, et al. Resurgence of Mycoplasma pneumonia by macrolide-resistant epidemic clones in China. The Lancet Microbe. 2024.
  • [36] Xu M, Li Y, Shi Y, et al. Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020–2022. BMC Microbiology. 2024;24(1).
  • [37] Xing F-F, Chiu KH-Y, Deng C-W, et al. Post-COVID-19 pandemic rebound of macrolide-resistant Mycoplasma pneumoniae infection: A descriptive study. Antibiotics. 2024;13(3):262. Tables

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.